Worth Venture Partners, LLC Context Therapeutics Inc. Transaction History

Worth Venture Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.61 - $1.42 $24,850 - $57,849	-40,739 Reduced 12.63%	281,889 $183,000
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.08 $27,767 - $52,033	25,016 Added 8.41%	322,628 $358,000
Q2 2022 Aug 15, 2022	SELL	$1.29 - $2.66 $25,950 - $53,511	-20,117 Reduced 6.33%	297,612 $565,000
Q1 2022 May 16, 2022	BUY	$1.72 - $2.82 $245,550 - $402,588	142,762 Added 81.59%	317,729 $689,000
Q4 2021 Feb 14, 2022	BUY	$2.66 - $7.45 $465,412 - $1.3 Million	174,967 New	174,967 $465,000

56.9M

Ticker CNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,966,100
Market Cap $16.3M
Description
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.